Delivery Order 36F79720D0189-36C26123N0765
Award Date
7/28/23
Potential Completion Date
9/28/23
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Incyte Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Talleyville, DE 19803, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725 delivery order against Incyte Corporation's Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. This firm fixed price order is to provide PEMIGATINIB/PEMAZYRE 4.5MG tablets for use in VA's healthcare programs from November 3rd to December 4th, 2023. Place of performance will be Incyte's facility in Talleyville, Delaware. No subcontractors or set aside...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded Incyte Corporation a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to provide 13.5mg tabs of pemigatinib (Pemazyre). Performance will occur in Talleyville, Delaware by the fixed price completion date of November 15, 2020. The delivery order was awarded on October 29, 2020 with no set-aside designation specified. Pemazyre will be...
Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The firm fixed price order is for the drug PEMAZYRE and has a completion date of December 31, 2020. The contract was awarded on November 18, 2020 and utilizes Master Schedule contract FSS-61-IB, which provides pharmaceuticals and drugs to government agencies. The...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded Incyte Corporation a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for a firm fixed price. The order is for PEMAZYRE 9 MG tablets to fulfill requirements under the referenced master agreement. Performance will take place in San Diego, California with completion by July 28, 2021. No set-aside provisions were applied to this...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $12,725.23 firm fixed price call against the Pharmaceuticals and Drugs Federal Supply Schedule to Incyte Corporation for the delivery of PEMAZYRE tablets. The contract has a completion date of September 5, 2021 and was awarded on August 6, 2021 without a set-aside designation. Under this contract, Incyte Corporation will provide the requested pharmaceutical products to support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $12,725.23 delivery order to Incyte Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The firm fixed price order is for PEMAZYRE 9 MG tablets to fulfill requirements through September 30th, 2022. Place of performance will be Incyte Corporation's location in West Chester Township, Ohio. No set-aside designation was applied to this order to...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21 to Incyte Corporation, a global biopharmaceutical company. The $13,290.97 delivery order contract is for the drug Pemigatinib, which is used to treat certain types of cancer. The contract was awarded under Incyte's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, and has a firm fixed price. No set-aside...
Incyte Corporation was awarded a $25,450.46 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The order, which has a completion date of October 31, 2022, is for the drug PEMAZYRE to be delivered to a location in West Chester Township, Ohio. No set-aside designation was used for this award issued under master GSA Schedule contract FSS-61-IB. The pricing is firm...
Incyte Corporation was awarded a $13,290.97 delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply pharmaceutical products under the Pharmaceuticals and Drugs Federal Supply Schedule. The order was issued against Incyte's FSS-61-IB schedule contract for the delivery of pharmacy items to the Talleyville, Delaware location. Incyte will fulfill the order as the prime contractor on a firm fixed price basis by the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $360,826.88 firm fixed price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., with parent company Lantheus Holdings, Inc. The order is for the drug PYLARIFY and has a period of performance through January 15, 2025 with no set-aside designation used. PYLARIFY will likely be...